TrialThe oncologist2023

Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study.

Ari Pelcovits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.